Paul Colvin, EVP--Clinical Development at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 5,759 shares at $28.70 ($165K) on 2011-05-27, disclosed to the SEC on 2011-05-27.
Open-market sale of $165k PPDI by EVP--Clinical Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.70 | 100 | $3K | 1.7% |
| 2 | $28.70 | 5,659 | $162K | 98.3% |
| Total | $28.70 avg | 5,759 | $165K | 100% |
| Filing → |
| PPDI | SELL | 2011-05-23 | $17K | — | Filing → |